These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17625938)

  • 21. Active comparator-controlled, rater-blinded study of corticotropin-based immunotherapies for opsoclonus-myoclonus syndrome.
    Tate ED; Pranzatelli MR; Verhulst SJ; Markwell SJ; Franz DN; Graf WD; Joseph SA; Khakoo YN; Lo WD; Mitchell WG; Sivaswamy L
    J Child Neurol; 2012 Jul; 27(7):875-84. PubMed ID: 22378659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Tate ED; Hoefgen ER; Swan JA; Colliver JA
    Cytokine; 2008 Oct; 44(1):26-32. PubMed ID: 18675552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome.
    Gorman MP
    Curr Opin Pediatr; 2010 Dec; 22(6):745-50. PubMed ID: 20871403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal neurodevelopmental evaluation of children with opsoclonus-ataxia.
    Mitchell WG; Brumm VL; Azen CG; Patterson KE; Aller SK; Rodriguez J
    Pediatrics; 2005 Oct; 116(4):901-7. PubMed ID: 16199699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of low-dose cyclophosphamide, ACTH, and IVIG combination immunotherapy on neuroinflammation in pediatric-onset OMS: A retrospective pilot study.
    Pranzatelli MR; Allison TJ; Tate ED
    Eur J Paediatr Neurol; 2018 Jul; 22(4):586-594. PubMed ID: 29555260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.
    Matthay KK; Blaes F; Hero B; Plantaz D; De Alarcon P; Mitchell WG; Pike M; Pistoia V
    Cancer Lett; 2005 Oct; 228(1-2):275-82. PubMed ID: 15922508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab treatment for relapsed opsoclonus-myoclonus syndrome.
    Toyoshima D; Morisada N; Takami Y; Kidokoro H; Nishiyama M; Nakagawa T; Ninchoji T; Nozu K; Takeshima Y; Takada S; Nishio H; Iijima K
    Brain Dev; 2016 Mar; 38(3):346-9. PubMed ID: 26375512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
    Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
    Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opsoclonus-myoclonus in children associated or not with neuroblastoma.
    Krug P; Schleiermacher G; Michon J; Valteau-Couanet D; Brisse H; Peuchmaur M; Sarnacki S; Martelli H; Desguerre I; Tardieu M
    Eur J Paediatr Neurol; 2010 Sep; 14(5):400-9. PubMed ID: 20110181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome and prognostic features in opsoclonus-myoclonus syndrome from infancy to adult life.
    Brunklaus A; Pohl K; Zuberi SM; de Sousa C
    Pediatrics; 2011 Aug; 128(2):e388-94. PubMed ID: 21788225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS).
    Krasenbrink I; Fühlhuber V; Juhasz-Boess I; Stolz E; Hahn A; Kaps M; Hero B; Blaes F
    Neuropediatrics; 2007 Jun; 38(3):114-6. PubMed ID: 17985258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of Opsoclonus-Myoclonus Syndrome in Patients of the Largest Pediatric Hospital in Latin America.
    Zeny MS; do Valle DA; Santos MLSF; Bara TS; Cordeiro ML
    Pediatr Neurol; 2024 May; 154():9-14. PubMed ID: 38430891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Opsoclonus-myoclonus syndrome].
    Arroyo HA; Tringler N
    Medicina (B Aires); 2009; 69(1 Pt 1):64-70. PubMed ID: 19240003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opsoclonus-myoclonus syndrome: a clinicopathological confrontation.
    Baets J; Pals P; Bergmans B; Foncke E; Smets K; Hauman H; Vanderwegen L; Cras P
    Acta Neurol Belg; 2006 Sep; 106(3):142-6. PubMed ID: 17091618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opsoclonus-myoclonus syndrome.
    Pike M
    Handb Clin Neurol; 2013; 112():1209-11. PubMed ID: 23622330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-related opsoclonus-myoclonus-ataxia syndrome: report on two cases.
    Kanjanasut N; Phanthumchinda K; Bhidayasiri R
    Clin Neurol Neurosurg; 2010 Sep; 112(7):572-4. PubMed ID: 20427123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies in childhood opsoclonus-myoclonus syndrome.
    Blaes F; Pike MG; Lang B
    J Neuroimmunol; 2008 Sep; 201-202():221-6. PubMed ID: 18687475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New autoantibodies in pediatric opsoclonus myoclonus syndrome.
    Kirsten A; Beck S; Fühlhuber V; Kaps M; Kreutz T; Korfei M; Schmitt S; Preissner KT; Blaes F
    Ann N Y Acad Sci; 2007 Sep; 1110():256-60. PubMed ID: 17911440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma.
    Raffaghello L; Conte M; De Grandis E; Pistoia V
    Eur J Paediatr Neurol; 2009 May; 13(3):219-23. PubMed ID: 18571942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome.
    Pranzatelli MR; Tate ED
    Brain Dev; 2016 May; 38(5):439-48. PubMed ID: 26786246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.